Please login to the form below

Not currently logged in
Email:
Password:

ALKS 3831

This page shows the latest ALKS 3831 news and features for those working in and with pharma, biotech and healthcare.

Troubled Alkermes eyes November OK for new antipsychotic

Troubled Alkermes eyes November OK for new antipsychotic

Review begins for potential schizophrenia and bipolar I disorder drug. The FDA has started its review of Alkermes’ experimental antipsychotic for schizophrenia and bipolar I disorder – ALKS 3831 – setting up a ... That left Alkermes more reliant on

Latest news

  • Alkermes slumps as FDA turns down depression drug Alkermes slumps as FDA turns down depression drug

    Alkermes has been hit hard by the FDA’s rejection of antidepressant candidate ALKS 5461 - citing a lack of evidence that it was clinically effective. ... The setback for ALKS 5461 will leave Alkermes more reliant on a positive read-out for

  • Alkermes depression drug misses targets in phase III Alkermes depression drug misses targets in phase III

    If that occurs, Alkermes said bundling that dataset with a successful phase II trial and the FORWARD-4 results could be enough to build a marketing application for ALKS 56461. ... This is overcome by giving it alongside samidorphan. Samidorphan is also

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics